Can patient selection for bladder preservation be based on response to chemotherapy? (Q61900098)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12655521%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Can patient selection for bladder preservation be based on response to chemotherapy? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12655521%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12655521%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Diana Giannarelli

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12655521%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

Vito Pansadoro

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12655521%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Sylvia Schnetzer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12655521%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Paolo Emiliozzi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12655521%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Francesco De Paula

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12655521%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Paolo Scarpone

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12655521%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Piero De Carli

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12655521%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Maurizio Pizzo

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12655521%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Andrea Platania

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12655521%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Mostafà Amini

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12655521%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Cora N Sternberg

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12655521%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

language of work or name

English

0 references

publication date

1 April 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12655521%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12655521%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

97

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12655521%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12655521%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

1644-1652

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12655521%20AND%20SRC:MED&resulttype=core&format=json

Prognostic factors of outcome after radical cystectomy for bladder cancer: a retrospective study of a homogeneous patient cohort

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11232

7 January 2021

Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11232

7 January 2021

Cystectomy for bladder cancer: a contemporary series

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11232

7 January 2021

Chemotherapy and management of bladder tumours.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11232

7 January 2021

Current perspectives in muscle invasive bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11232

7 January 2021

Bladder preservation by combined modality therapy for invasive bladder cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11232

7 January 2021

Selective bladder conservation using transurethral resection, chemotherapy, and radiation: management and consequences of Ta, T1, and Tis recurrence within the retained bladder

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11232

7 January 2021

Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy: initial results of Radiation Therapy Oncology Group 89-03

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11232

7 January 2021

Neoadjuvant m-vac (methotrexate, vinblastine, doxorubicin, and cisplatin) for infiltrating transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11232

7 January 2021

Neo-adjuvant chemotherapy and bladder preservation in locally advanced transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11232

7 January 2021

Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) effect on the primary bladder lesion.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11232

7 January 2021

Feasibility of transurethral resection for muscle infiltrating carcinoma of the bladder: long-term followup of a prospective study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11232

7 January 2021

Transurethral resection of muscle-invasive bladder cancer: 10-year outcome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11232

7 January 2021

Neoadjuvant chemotherapy for invasive bladder cancer: prognostic factors for survival of patients treated with M-VAC with 5-year follow-up.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11232

7 January 2021

Integrated therapy for locally advanced bladder cancer: final report of a randomized trial of cystectomy plus adjuvant M-VAC versus cystectomy with both preoperative and postoperative M-VAC

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11232

7 January 2021

A European Organization for Research and Treatment of Cancer--Genitourinary Group phase 2 study of chemotherapy in stage T3-4N0-XM0 transitional cell cancer of the bladder: evaluation of clinical response

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11232

7 January 2021

Neoadjuvant chemotherapy and bladder-sparing surgery for invasive bladder cancer: ten-year outcome

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11232

7 January 2021

Evaluation of clinical staging before cystectomy in transitional cell bladder carcinoma: a long-term follow-up of 276 consecutive patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11232

7 January 2021

Differences in gene expression in muscle-invasive bladder cancer: a comparison of Italian and American patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11232

7 January 2021

p53 and treatment of bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.11232

7 January 2021

Identifiers

DOI

10.1002/CNCR.11232

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12655521%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference